Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Oncotarget|March 19, 2016
Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cellsJosep Maria Cornet-Masana, Daniel Moreno-Martínez, María Carmen Lara-Castillo, et al.Leukemia Research|June 2, 2014
High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndromeXavier Calvo, Meritxell Nomdedeu, Alfons Navarro, et al.Journal of Translational Medicine|September 9, 2016
Repositioning of bromocriptine for treatment of acute myeloid leukemiaMaría Carmen Lara-Castillo, Josep Maria Cornet-Masana, Amaia Etxabe, et al.Acta Haematologica|October 29, 2015
Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic SyndromesDolors Costa, Concha Muñoz, Ana Carrió, et al.Cancer Cell International|December 24, 2015
Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stromaMeritxell Nomdedeu, María Carmen Lara-Castillo, Amaia Etxabe, et al.Vaccine|August 29, 2009
Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccineAnna López, Nils van der Lubbe, Sonsoles Sánchez-Palomino, et al.Oncotarget|June 23, 2014
XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cellsDaniel Moreno-Martínez, Meritxell Nomdedeu, María Carmen Lara-Castillo, et al.Immunology|January 14, 2010
Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activationJosé M Martinez-Navio, Núria Climent, Rodrigo Pacheco, et al.Immunotherapy|July 20, 2010
Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patientsAlba Ruiz, Meritxell Nomdedeu, Marisa Ortega, et al.Scientific Reports|September 19, 2018
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMMLAntònia Banús-Mulet, Amaia Etxabe, Josep Maria Cornet-Masana, et al.Pageof 5